OKYO Pharma Limited
OKYO
Equity
ISIN GG00BMFG5F62 / Valor 127195533
UTP NYSE Arca (2024-09-18)
USD 1.03-2.42%
OKYO Pharma Limited
UMushroom community rating:
About company
OKYO Pharma Limited is a biotechnology company focused on developing therapies for inflammatory dry eye diseases and chronic pain management.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
-44.7%1Y
%3Y
%5Y
Performance
99.5%1Y
114%3Y
114%5Y
Volatility
2405 M
Market cap (USD)
12
Daily traded volume (Shares)
1.06 / 1.035
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
